PA
RMD icon

Pinnacle Associates’s ResMed RMD Stock Holding History

Pinnacle Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.03M Sell
20,674
-8,110
-28% -$1.68M 0.04% 308
2026
Q1 		$6.46M Sell
28,784
-701
-2% -$175K 0.08% 224
2025
Q4 		$7.1M Sell
29,485
-222
-0.7% -$56.8K 0.09% 214
2025
Q3 		$8.13M Sell
29,707
-56
-0.2% -$15.3K 0.11% 189
2025
Q2 		$7.68M Sell
29,763
-3,354
-10% -$800K 0.11% 185
2025
Q1 		$7.41M Sell
33,117
-2,336
-7% -$545K 0.11% 190
2024
Q4 		$8.11M Buy
+35,453
New +$8.54M 0.11% 183
2024
Q3 		– Sell
-36,716
Closed -$7.03M – 837
2024
Q2 		$7.03M Sell
36,716
-501
-1% -$102K 0.11% 196
2024
Q1 		$7.37M Buy
+37,217
New +$6.82M 0.12% 194

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pinnacle Associates's RMD Position: Q2 2026 in Review

Pinnacle Associates reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $1.68M and leaving 20,674 shares worth $4.03M. The position accounts for 0.04% of the portfolio, ranked #308.

Pinnacle Associates first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $8.13M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Pinnacle Associates held 20,674 shares of ResMed worth $4.03M as of Q2 2026.
  • Pinnacle Associates sold 8,110 ResMed shares in Q2 2026, an estimated $1.68M.
  • ResMed made up 0.04% of Pinnacle Associates's portfolio in Q2 2026, its #308 holding.
  • Pinnacle Associates first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • Pinnacle Associates's ResMed position peaked at $8.13M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.